FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ZYPREXA ZYDIS (olanzapine)

Snippet

SUPPL AP for ZYPREXA ZYDIS (OLANZAPINE)